Measles Control Program A Global and India ... - The INCLEN Trust
Measles Control Program A Global and India ... - The INCLEN Trust
Measles Control Program A Global and India ... - The INCLEN Trust
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>Measles</strong> <strong>Control</strong> <strong>Program</strong><br />
A <strong>Global</strong> <strong>and</strong> <strong>India</strong> Update<br />
CHF – INCLEAN Advanced Vaccinology Course September 23, 2011<br />
Edward Hoekstra, MD, MSc, UNICEF<br />
Peter Strebel, MBChB, MPH, WHO
number of cases<br />
1980<br />
1981<br />
1982<br />
1983<br />
1984<br />
1985<br />
1986<br />
1987<br />
1988<br />
1989<br />
1990<br />
1991<br />
1992<br />
1993<br />
1994<br />
1995<br />
1996<br />
1997<br />
1998<br />
1999<br />
2000<br />
2001<br />
2002<br />
2003<br />
2004<br />
2005<br />
2006<br />
2007<br />
2008<br />
2009<br />
2010<br />
immunization coverage (%)<br />
Overview<br />
5,000,000<br />
4,500,000<br />
4,000,000<br />
3,500,000<br />
3,000,000<br />
2,500,000<br />
2,000,000<br />
1,500,000<br />
1,000,000<br />
500,000<br />
0<br />
<strong>Measles</strong> global annual reported cases<br />
<strong>and</strong> MCV coverage, 1980 to 2010<br />
Campaigns<br />
100<br />
90<br />
80<br />
70<br />
60<br />
50<br />
40<br />
30<br />
20<br />
10<br />
0<br />
• Progress<br />
• Challenges<br />
• Opportunities<br />
Number of cases<br />
WHO/UNICEF estimates<br />
2 |
Burden of measles in 2000<br />
• 40 million cases<br />
• Complications:<br />
– 8% pneumonia<br />
– 1:1,000 encephalitis<br />
– 1:10,000 blindness<br />
• 500,000 deaths
Strategy for measles mortality reduction<br />
1. Strong routine immunization > 90%<br />
2. Provide second dose through routine<br />
or campaign<br />
3. Surveillance<br />
4. Introduction of AD syringes
Number of reported cases<br />
vaccination coverage (%)<br />
Reported measles cases <strong>and</strong> measles<br />
vaccination coverage, 1990 - 2006, Ghana<br />
45,000<br />
2001-2002<br />
campaign<br />
2006<br />
campaign<br />
100<br />
40,000<br />
90<br />
35,000<br />
30,000<br />
25,000<br />
20,000<br />
15,000<br />
10,000<br />
5,000<br />
0<br />
1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006*<br />
80<br />
70<br />
60<br />
50<br />
40<br />
30<br />
20<br />
10<br />
0<br />
measles cases<br />
measles vaccination coverage
<strong>Global</strong> Goals<br />
• Millennium development goal # 4 :<br />
– Reduce child deaths among children by 2/3 by 2015 ( vs. 1990 )<br />
– <strong>Measles</strong> immunization coverage indicator of access to care<br />
• By 2005<br />
– 50 % reduction in measles deaths ( achieved on time )<br />
• By 2010<br />
– 90 % reduction in measles deaths ( achieved in 5/6 WHO Regions )<br />
• By 2015<br />
– Vaccination coverage: 90 % national level <strong>and</strong> 80 % in every district<br />
– Reported incidence: < 5 cases of measles per million<br />
– Mortality reduction: 95 % ( vs 2000 )
<strong>Measles</strong> <strong>and</strong> Rubella Elimination Goals<br />
by WHO Region, August 2011<br />
Americas, Europe, E. Mediterranean, W. Pacific, Africa have measles elimination goals<br />
Americas <strong>and</strong> Europe have rubella elimination goals<br />
2015<br />
2015<br />
2000<br />
2010<br />
2015<br />
2012<br />
2020<br />
SEAR: 95% <strong>Measles</strong><br />
Mortality Reduction<br />
by 2015
Feasibility of <strong>Measles</strong> Eradication<br />
• July 2010 – <strong>Global</strong> Consultation<br />
– <strong>Measles</strong> can <strong>and</strong> should be<br />
eradicated<br />
– In the context of strengthening<br />
immunization <strong>and</strong> primary health<br />
care systems<br />
– Opportunity to accelerate rubella<br />
control <strong>and</strong> the prevention of<br />
congenital rubella syndrome<br />
– Target date of 2020 feasible if<br />
measurable progress
SAGE, November 2010<br />
• <strong>Measles</strong> can <strong>and</strong> should be eradicated<br />
• Measurable progress towards 2015 global targets <strong>and</strong><br />
existing regional elimination goals is required before<br />
establishing a target date<br />
• Requested frequent updates on progress<br />
• Executive Board (Jan 2011) endorsed SAGE approach
Progress towards 2015 global<br />
targets
Since 2000, global coverage of<br />
the first dose of measles -<br />
containing vaccine (MCV1) has<br />
increased from 72 % to :<br />
A 74 %<br />
B 78 %<br />
C 85 %<br />
D 89 %
MCV coverage (%)<br />
1980<br />
1981<br />
1982<br />
1983<br />
1984<br />
1985<br />
1986<br />
1987<br />
1988<br />
1989<br />
1990<br />
1991<br />
1992<br />
1993<br />
1994<br />
1995<br />
1996<br />
1997<br />
1998<br />
1999<br />
2000<br />
2001<br />
2002<br />
2003<br />
2004<br />
2005<br />
2006<br />
2007<br />
2008<br />
2009<br />
2010<br />
Since 2001, 1 st dose coverage up by 12%<br />
120<br />
2015 Target<br />
100<br />
80<br />
60<br />
40<br />
20<br />
0<br />
16 19 20<br />
37 41 47 47 53 62 68 73 69 69 70 71 73 73 71 71 71 72 73 73 74 76 78 81 82 83 84 85<br />
<strong>Global</strong> AFR AMR EMR<br />
EUR SEAR WPR<br />
12 |<br />
Source: WHO/UNICEF coverage<br />
estimates, 2011 revision. Date of slide:<br />
29 July 2011
Number of MCV doses (in millions)<br />
Scaling-up 2 nd Dose Strategies<br />
Number of doses of measles vaccine administered, by delivery strategy, 2000 - 2010<br />
500<br />
450<br />
400<br />
350<br />
300<br />
<strong>Measles</strong> Initiative<br />
250<br />
200<br />
1 billion vaccinated<br />
as of July 2011<br />
150<br />
100<br />
50<br />
0<br />
2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010<br />
1st routine dose 2nd routine dose SIA<br />
13 |<br />
1 st routine dose: WHO/UNICEF coverage estimates, <strong>The</strong> World<br />
Population Prospects New York, 2011. 2 nd routine dose: WHO/UNICEF<br />
Joint reporting form, (not all countries report 2 nd dose). SIA dose;: WHO<br />
SIA database, July 2011 (Provisional data)
Number of reported cases<br />
Reported measles cases<br />
down by two-thirds<br />
900000<br />
800000<br />
Reported number of measles cases by WHO Region, 2000-<br />
2010<br />
700000<br />
600000<br />
500000<br />
400000<br />
300000<br />
200000<br />
100000<br />
0<br />
2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010<br />
AFR AMR EMR EUR SEAR WPR<br />
14 |<br />
Source: Cases from annual Joint Reporting Form<br />
193 WHO Member States, Data as of August 2011
1000<br />
250 500 750<br />
0<br />
Reported cases, thous<strong>and</strong>s<br />
0 400 800 1200 1600 2000<br />
Estimated <strong>Global</strong> <strong>Measles</strong> Deaths<br />
have decreased by three-quarters, 2000-2010<br />
76%<br />
2015 Target<br />
2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010<br />
Year<br />
Estimated mortality<br />
Reported cases<br />
15 |<br />
PROVISIONAL ESTIMATES<br />
Source: 2010 WHO/IVB measles model, Sept 2011<br />
Shading indicates uncertainty bounds
% Reduction<br />
Reduction in Estimated <strong>Measles</strong> Deaths by<br />
WHO Region 2000 to 2010<br />
0<br />
-10<br />
-20<br />
AMR EUR AFR WPR EMR SEAR* <strong>India</strong> GLOBAL<br />
26%<br />
-30<br />
-40<br />
-50<br />
87% 85% 79% 78%<br />
85%<br />
76%<br />
-60<br />
-70<br />
-80<br />
-90<br />
-100<br />
95% 2015 reduction goal<br />
16 |<br />
* SEAR excluding <strong>India</strong><br />
Source: 2010 measles burden model,<br />
WHO/IVB, September 2011
Major causes of mortality among children
Deaths Averted<br />
<strong>Measles</strong> Deaths Averted, 2000-2010<br />
2,000<br />
1,800<br />
1,600<br />
1,400<br />
1,200<br />
5.0 million deaths<br />
averted (32%)<br />
1,000<br />
800<br />
600<br />
400<br />
10.8 million deaths<br />
averted (68%)<br />
200<br />
-<br />
2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010<br />
Total deaths averted with SIA <strong>and</strong> improved RI<br />
Total deaths averted by sustaining year 2000 RI coverage<br />
18 |<br />
*Provisional estimates<br />
Based on method of Wolfson et al, Lancet 2007
Challenges
# 1: <strong>India</strong><br />
• 134 million children need<br />
vaccination<br />
• High quality<br />
– Coverage >90%<br />
– Immunization safety including<br />
needle disposal<br />
20 |
Estimated <strong>Measles</strong> Mortality, <strong>India</strong><br />
60000<br />
50000<br />
40000<br />
30000<br />
20000<br />
10000<br />
0<br />
Arunachal Pradesh<br />
Manipur<br />
J & K<br />
Tripura<br />
Source: <strong>Measles</strong> Strategic Planning model<br />
60,000- 100,000 estimated<br />
deaths<br />
Meghalaya<br />
Nagal<strong>and</strong><br />
Punjab<br />
Uttarakh<strong>and</strong><br />
Haryana<br />
Karnataka<br />
Chattisgarh<br />
Maharashtra<br />
Gujarat<br />
Orissa<br />
Andhra Pradesh<br />
West Bengal<br />
Assam<br />
Jharkh<strong>and</strong><br />
Madhya Pradesh<br />
Rajasthan<br />
Bihar<br />
Uttar Pradesh<br />
>80% deaths
MCV1: Coverage of <strong>Measles</strong> containing vaccine<br />
per DLHS-3; CES-06 for Nagal<strong>and</strong><br />
2 nd Dose of <strong>Measles</strong> vaccine:<br />
State specific delivery strategies<br />
SIA: MCV1 < 80%<br />
RI: MCV1 > 80%
2 nd Dose of<br />
<strong>Measles</strong> in RI<br />
• 17 states (MCV1 > 80 %)<br />
introduced measles 2 nd<br />
dose in their routine<br />
immunization program<br />
• 45 districts, who<br />
completed measles<br />
campaign in phase -1 are<br />
in process of introducing<br />
2 nd dose in their RI<br />
program
MCV2 introduction through Supplementary<br />
Immunization Activity (SIA) in Phases<br />
Phase 1<br />
• Initiated in November 2010;<br />
• 45 districts from 13 states<br />
o 9 district from Chhattisgarh<br />
o 5 districts from each of the 6<br />
states (Bihar, Jharkh<strong>and</strong>,<br />
Rajasthan, Madhya Pradesh,<br />
Gujarat & Haryana)<br />
o 1 district from each of the 6<br />
North-East states<br />
• Approximately 14 million target<br />
children 9 months – 10 yrs
<strong>Measles</strong> SIA plan, <strong>India</strong><br />
Phase 1, 45 districts covered<br />
Phase 2 A (144 districts)<br />
Phase 2 B (81 districts)<br />
Phase 3 (91 districts)<br />
Total target- 135 million children<br />
Districts- 361
No. of cases (in thous<strong>and</strong>s)<br />
MCV1 coverage (%)<br />
# 2: Resurgence in Africa<br />
• 4-fold increase since 2008<br />
600,000<br />
500,000<br />
400,000<br />
100<br />
90<br />
80<br />
70<br />
60<br />
• Large outbreaks in Burkina<br />
Faso (2009), S. Africa (2010),<br />
<strong>and</strong> DRC (2011)<br />
300,000<br />
200,000<br />
100,000<br />
Number of cases<br />
WHO/UNICEF estimates<br />
Administrative coverage<br />
50<br />
40<br />
30<br />
20<br />
• Outbreaks in drought affected<br />
Horn of Africa<br />
– High case-fatality<br />
10<br />
0<br />
0<br />
2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010‡<br />
Year<br />
26 |<br />
Weekly Epidemiological Record<br />
(2011) 86:129-136
# 3: Weak Immunization Systems<br />
<strong>Measles</strong> 1 st dose coverage among infants, 2010<br />
• 1 st dose:<br />
– 67 Countries have<br />
MCV1 coverage
$ US Million<br />
# 4: Financing is late <strong>and</strong> unpredictable<br />
180<br />
<strong>Measles</strong> Initiative Annual Donations, 2001-2011*<br />
160<br />
140<br />
120<br />
100<br />
80<br />
60<br />
40<br />
20<br />
0<br />
2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011<br />
*Excluding country contributions<br />
Donations<br />
28 |
Summary<br />
• <strong>Measles</strong> strategy works<br />
• Achievements<br />
– 1 st dose coverage up to 85%<br />
– 1 billion doses delivered in campaigns<br />
– 2 / 3 reduction in cases<br />
– 3 / 4 reduction in deaths<br />
• Challenges<br />
– Cases <strong>and</strong> deaths unchanged in past 3 years<br />
29 |
Anne Ray Charitable <strong>Trust</strong>